Reduction of Abdominal Obesity in Lipodystrophy Associated with Human Immunodeficiency Virus Infection by Means of Diet and Exercise: Case Report and Proof of Principle
Author(s) -
Ronenn Roubenoff,
H. Schmitz,
Lynn Bairos,
Jennifer E. Layne,
Erin N. Potts,
Gregory Cloutier,
F. Denry
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/338402
Subject(s) - lipodystrophy , medicine , abdominal obesity , insulin resistance , hypertriglyceridemia , atrophy , human immunodeficiency virus (hiv) , weight loss , endocrinology , obesity , gastroenterology , metabolic syndrome , immunology , triglyceride , antiretroviral therapy , cholesterol , viral load
Lipodystrophy associated with human immunodeficiency virus infection causes abdominal fat gain, peripheral subcutaneous fat atrophy, insulin resistance, low levels of high-density lipoprotein cholesterol, and hypertriglyceridemia. An exercise program combined with a moderate-fat, low-glycemic-index, high-fiber diet can reverse several aspects of lipodystrophy, and, until specific treatment is available, should be considered for treatment of lipodystrophy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom